August 2, 2022 Research Bulletin
Volume 3, Issue 15
Featured Funding Opportunities
- 09/27/22 - HEAL Initiative: Multilevel Interventions to Reduce Harm and Improve Quality of Life for Patients on Long Term Opioid Therapy (MIRHIQL): Resource Center (U24- Clinical Trial Optional)
- 10/10/22 - NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
- 10/12/22 - HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K23 - Clinical Trial Required)
- 10/13/22 - BRAIN Initiative: Transformative Brain Non-invasive Imaging Technology Development (UG3/UH3 Clinical Trial Not Allowed)
- 10/26/22– Chronic Kidney Disease in Children Central Biochemistry Laboratory (U24 Clinical Trial Not Allowed)
- 10/26/22 - Human Islet Research Network - Consortium on Targeting and Regeneration (HIRN-CTAR) (U01 Clinical Trial Not Allowed)
- 10/26/22 - Mass Spectrometric Assays for the Reliable and Reproducible Detection of Proteins/Peptides of Importance in Type 1 Diabetes (T1D) Research (U01 Clinical Trial Not Allowed)
- 10/27/22 - Galvanizing Health Equity Through Novel and Diverse Educational Resources (GENDER) Research Education R25 (R25 Clinical Trial Not Allowed)
- 11/18/22 - Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases (U44 Clinical Trial Required)
- 12/05/22 - Epigenetic Mechanisms Regulating HIV CNS Latency and Neuropathogenesis Using Novel Single Cell Technologies (R21 Clinical Trial Not Allowed)
- 12/05/22 - Epigenetic Mechanisms Regulating HIV CNS Latency and Neuropathogenesis Using Novel Single Cell Technologies (R01 Clinical Trial Not Allowed)
- 12/20/22 - Understanding the Pathophysiology and Clinical Course of New-Onset Diabetes Following COVID-19 (U01 Clinical Trial Not Allowed)
- 02/02/23 - HEAL Initiative: Preventing Opioid Misuse and Co-Occurring Conditions by Intervening on Social Determinants (R01 Clinical Trials Optional)
- 02/28/23 - Collaborative Research Using Biosamples from Type 1 Diabetes Clinical Studies (R01 - Clinical Trial Not Allowed)
NIH Funding Announcements
NIH funding opportunities and notices are presented weekly. Please see the current and past updates below.
Limited Funding Opportunities
Please take a moment to visit and bookmark the newly launched website featuring limited funding opportunities.
To submit a proposal for these opportunities:
Interested candidates must send a one-page summary of their research proposal and their biosketch in pdf format via the Limited Submission Portal.
Simons Foundation Simons Investigators
- Materials due to Internal Review Committee: September 6, 2022
- Sponsor Deadline: November 7, 2022
Modern Equipment for Shared-use Biomedical Research Facilities: Advancing Research-Related Operations
- Materials due to Internal Review Committee: September 6, 2022
- Sponsor Deadline: November 7, 2022
Greenwall Faculty Scholars Program in Bioethics
- Materials due to Internal Review Committee: August 30, 2022
- Letter of Intent due to sponsor: September 19, 2022
- Sponsor Deadline: January 9, 2023
Special Announcements
The Food and Drug Administration’s (FDA) Office of Orphan Products Development (OOPD) announces the availabilty of funds for fiscal years (FY) 2023 - FY 2025 to support clinical trials for rare diseases and conditions.
The purpose of this funding opportunity announcement is to fund clinical trials of products evaluating efficacy and/or safety to address unmet needs in rare diseases or conditions, increasing the number of approved treatments for rare diseases.
Online applications are due Oct. 25 for FY2023 funding.
The National Science Foundation (NSF) has released a solicitation for applications for the Graduate Research Fellowship Program (GRFP).
The GRFP program recognizes and supports outstanding graduate students who are pursuing full-time research-based master's and doctoral degrees in science, technology, engineering, and mathematics (STEM) or in STEM education.
The fellowship will provide three years of support over a five-year fellowship period for the graduate education of individuals who have demonstrated their potential for significant research achievements in STEM or STEM education.
Due Date: Oct. 17 to Oct. 21, 2022 (depending on topic)
The Strategic Infrastructure for Research Committee (SIRC) is announcing a new pilot grant program - “Across the Finish Line” (AFL) grants - that are designed to help both junior faculty and established faculty moving into a new area of investigation.
Funds will be used to generate pilot data that can be leveraged into a new R01-type grant submission (or re-submission). Initially, grants will be reviewed by the standing SIRC review committee.
Priority will be given both to investigators who are perceived to have a high likelihood of funding success and to junior faculty who have limited resources available to support data generation.
The application must be submitted by 5pm on Wednesday, August 17, 2022.
For questions please visit the webpage or contact Peter Buttrick, MD
Over the past several years the Movement Disorders Center (MDC) has received philanthropic donations earmarked for movement disorders-related research. The leadership of the MDC feels these funds would be best used to invest in one-year pilot projects and young investigators with the objectives of increasing the chances of success for unique projects tied to the MDC and encouraging promising young investigators to pursue careers in research.
Please see the Request for Pilot Grant Applications for additional details.
The application deadline is Friday, August 19, 2022.
Should you have questions, please contact movement@ucdenver.edu.
The 2022-23 grant cycle will fund new initiatives for investigators who are pursuing joint-biology related research that should lead to NIH K/R type funding or other extramural support (e.g. foundations, industry, Department of Defense, etc.).
All application materials for pilot projects are due October 1, 2022 by 5pm MST.
Click here to learn more or see the list of past grant recipients.
This bulletin is distributed on the 1st & 3rd Tuesday of the month for the CU Anschutz Research Community.
Past Research Bulletins can be found here.
Please click here if you wish to be added to this distribution.